We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 830.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMINS
RNS Number : 8985H
Instem plc
16 March 2018
16 March 2018
Instem plc
("Instem" or the "Company")
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, will announce full year results for the year ended 31 December 2017 on Monday 26 March 2018.
Analyst Presentation
Management will be hosting a presentation on the day of the results at 10.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD. Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.
Investor Presentation
The Company will also be hosting a presentation for investors in London on Wednesday 28 March 2018. Phil Reason, CEO of the Company will present financial and operational results for the year ended 31 December 2017, as well as an overview of the Company and its plans for the future.
The event is open to all investors and will be held from 16.30 for a 16.45 start at a venue in the City. To register for the event, please email instem@walbrookpr.com or call the Walbrook PR team, below.
For further information, please contact:
Instem plc +44 (0) 1785 825 600 Phil Reason, CEO Nigel Goldsmith, CFO N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000 Richard Lindley James White Walbrook Financial PR +44 (0) 20 7933 8780 Paul Cornelius instem@walbrookpr.com Helen Cresswell Sam Allen
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit instem.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORZMGMFVKRGRZM
(END) Dow Jones Newswires
March 16, 2018 03:00 ET (07:00 GMT)
1 Year Instem Chart |
1 Month Instem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions